Nov 20, 2020
First-Ever Treatment for Rare Rapid-Aging Disease Progeria Receives U.S. FDA Approval
May 07, 2020
Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
Mar 13, 2020
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Jan 07, 2020
Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer
Aug 29, 2019
Eiger BioPharmaceuticals to Participate in September Conferences
Aug 08, 2019
Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
Aug 05, 2019
Eiger BioPharmaceuticals to Participate in Investor Conferences in August
Jun 10, 2019
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
May 30, 2019
Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
May 17, 2019
Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer
May 09, 2019
Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
Mar 14, 2019
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
Feb 27, 2019
Eiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance Officer
Dec 03, 2018
Eiger BioPharmaceuticals Announces the Appointment of Sri Ryali as Chief Financial Officer
Nov 09, 2018
Eiger Bio Reports Third Quarter 2018 Financial Results
Aug 27, 2018
Eiger BioPharmaceuticals to Participate in Investor Conferences
May 30, 2018
Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
Mar 12, 2018
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 06, 2018
Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March
Feb 06, 2018
Eiger BioPharmaceuticals to Participate in Two Upcoming Investor Conferences in February